Search results

Evidence-based recommendations on ibrutinib (Imbruvica) with venetoclax (Venclyxto) for untreated chronic lymphocytic leukaemia in adults.

Result type

Technology appraisal guidance

Published

31 May 2023

Evidence-based recommendations on lenvatinib (Kisplyx) with pembrolizumab (Keytruda) for untreated advanced renal cell carcinoma in adults.

Result type

Technology appraisal guidance

Published

11 January 2023

Evidence-based recommendations on ramucirumab (Cyramza) for treating advanced gastric cancer or gastro-oesophageal junction adenocarcinoma previously treated with chemotherapy.

Result type

Technology appraisal guidance

Published

27 January 2016

Evidence-based recommendations on nivolumab (Opdivo) for previously treated advanced renal cell carcinoma in adults.

Result type

Technology appraisal guidance

Published

23 November 2016

Evidence-based recommendations on tivozanib (Fotivda) for treating advanced renal cell carcinoma in adults.

Result type

Technology appraisal guidance

Published

21 March 2018

NICE has developed a medtech innovation briefing (MIB) on the Juxta CURES adjustable compression system for treating venous leg ulcers

Result type

Medtech innovation briefing

Published

25 March 2015

In development Reference number: GID-HTE10077 Expected publication date: TBC

Result type

Health technology evaluations

Status

In development

This guideline covers the diagnosis and management of gout. It includes recommendations on diagnosing gout, managing flares, long-term management of gout and referral to specialist services.

Result type

NICE guideline

Published

9 June 2022

This guideline covers diagnosing and managing cystic fibrosis. It specifies how to monitor the condition and manage the symptoms to improve quality of life. There are also detailed recommendations on treating the most common infections in people with cystic fibrosis.

Result type

NICE guideline

Published

25 October 2017

This guideline covers managing diabetes and its complications in women who are planning pregnancy or are already pregnant. It aims to improve the diagnosis of gestational diabetes and help women with diabetes to self-manage their blood glucose levels before and during pregnancy.

Result type

NICE guideline

Last updated

16 December 2020

Evidence-based recommendations on cetuximab (Erbitux), bevacizumab (Avastin) and panitumumab (Vectibix) for treating metastatic colorectal cancer in adults.

Result type

Technology appraisal guidance

Published

25 January 2012

Evidence-based recommendations on omalizumab (Xolair) for treating severe chronic spontaneous urticaria in people of 12 and over.

Result type

Technology appraisal guidance

Published

8 June 2015

Evidence-based recommendations on enzalutamide (Xtandi) for treating high-risk hormone-relapsed non-metastatic prostate cancer in adults.

Result type

Technology appraisal guidance

Published

15 May 2019

Evidence-based recommendations on rituximab (MabThera) with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in adults.

Result type

Technology appraisal guidance

Published

26 March 2014

Evidence-based recommendations on balloon angioplasty with or without stenting for coarctation or recoarctation of the aorta in adults and children. This involves gently inflating a balloon in the narrow area of the aorta to widen it so blood can flow more easily.

Result type

Interventional procedures guidance

Published

28 July 2004